Biotech Investment Analyst

Posted 14hrs ago

Employment Information

Education
Salary
Experience
Job Type

Report this job

Job expired or something wrong with this job?

Job Description

Biotech investment analyst evaluating drug assets, clinical programmes, and pharmaceutical companies for 24-MAG LLC. Developing rubrics and investment assessments for US biotech opportunities.

Responsibilities:

  • Evaluate commercial and clinical-stage drug assets across different therapeutic areas
  • Assess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerations
  • Analyse competitive positioning within relevant therapeutic and treatment landscapes
  • Identify scientific, clinical, regulatory, and commercial value drivers
  • Flag unsupported assumptions, evidence gaps, or material risks within asset assessments
  • Conduct end-to-end assessments of biotech and pharmaceutical companies
  • Evaluate pipeline quality, company strategy, competitive differentiation, and major catalysts
  • Assess the relationship between individual drug assets and overall company valuation
  • Review investment-style theses for analytical strength, supporting evidence, and internal consistency
  • Apply consistent investment judgement across approximately 5–10 companies during the pilot
  • Interpret clinical trial results and assess the strength and relevance of available evidence
  • Evaluate potential differentiation against existing and emerging standards of care
  • Analyse addressable markets, competitive dynamics, development timelines, and commercial opportunity
  • Assess how clinical, regulatory, and market developments may affect asset and company value
  • Distinguish between well-supported conclusions and speculative investment assumptions
  • Create structured evaluation rubrics for biotech companies and drug-development programmes
  • Critique existing rubrics for completeness, realism, and investment relevance
  • Define criteria reflecting experienced biotech investment judgement
  • Identify missing considerations or weak assumptions in analytical frameworks
  • Provide clear written reasoning supporting evaluation decisions

Requirements:

  • 5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assets
  • Professional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fund
  • Strong familiarity with biotech and pharmaceutical drug-development programmes
  • Experience assessing drug assets from scientific, clinical, commercial, and investment perspectives
  • Strong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation drivers
  • Ability to evaluate both individual assets and the broader companies developing them
  • Experience developing, reviewing, or presenting investment theses
  • Strong analytical judgement and ability to identify unsupported or incomplete assumptions
  • US-based or possessing deep professional experience covering the US biotech and healthcare investment market
  • Availability for approximately 10–20 hours over an initial 1–2 week pilot
  • Part-time independent contractor engagement
  • Work must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third party
  • H1-B and STEM OPT support is unavailable for this engagement

Benefits:

  • Fully remote with flexible scheduling
  • Compensation of $125–$185/hour
  • Potential for recurring project work for strong contributors